Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna S. Kreutzman
Observed names:
A Kreutzman,
A. Kreutzman,
Anna Kreutzman,
Kreutzman, Anna
Institutions:
University of Helsinki,
Helsinki University Hospital
Observed institutions:
University of Helsinki,
University of Turku,
Helsinki University Hospital,
Bristol-Myers Squibb (United States),
Hospital Universitario de La Princesa,
Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa,
Universidad Autónoma de Madrid
show all 7
ORCID:
0000-0002-5587-8844
Observed ORCID:
0000-0002-5587-8844
OpenAlex ID:
A5030901471
Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
2010
·
Anna Kreutzman
, Vesa Juvonen
, et al.
·
Blood
·
173
Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation
2011
·
A Kreutzman
, K Ladell
, et al.
·
Leukemia
·
101
Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma
2023
·
Jani Huuhtanen
, Henna Kasanen
, et al.
·
Journal of Clinical Investigation
·
98
PDF
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy
2012
·
S Mustjoki
, K Auvinen
, et al.
·
Leukemia
·
94
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
2021
·
Firas Hamdan
, Erkko Ylösmäki
, et al.
·
Journal for ImmunoTherapy of Cancer
·
56
PDF
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
2021
·
Erkko Ylösmäki
, Leena Ylösmäki
, et al.
·
Molecular Therapy — Oncolytics
·
51
PDF
Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile
2011
·
Anna Kreutzman
, Peter Rohon
, et al.
·
PLoS ONE
·
49
PDF
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
2023
·
Jani Huuhtanen
, Shady Adnan-Awad
, et al.
·
Leukemia
·
48
PDF
Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2017
·
Anna Kreutzman
, Beatriz Colom-Fernández
, et al.
·
Clinical Cancer Research
·
47
Dasatinib promotes Th1-type responses in granzyme B expressing T-cells
2014
·
Anna Kreutzman
, Mette Ilander
, et al.
·
OncoImmunology
·
42
PDF
Evolution and modulation of antigen-specific T cell responses in melanoma patients
2022
·
Jani Huuhtanen
, Liang Chen
, et al.
·
Nature Communications
·
40
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients
2021
·
Oscar Brück
, Moon Hee Lee
, et al.
·
Modern Pathology
·
40
PDF
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
2021
·
Jacopo Chiaro
, Henna H.E. Kasanen
, et al.
·
Cancer Immunology Research
·
40
PDF
Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy
2014
·
Mette Ilander
, Anna Kreutzman
, et al.
·
PLoS ONE
·
40
PDF
Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication
2017
·
A Arteche-López
, A Kreutzman
, et al.
·
Bone Marrow Transplantation
·
33
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma
2022
·
Moon Hee Lee
, Petrus Järvinen
, et al.
·
OncoImmunology
·
32
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
2020
·
Carlos Cuesta-Mateos
, Patricia Fuentes
, et al.
·
Biomarker Research
·
30
PDF
Immune cell phenotype and functional defects in Netherton syndrome
2018
·
Elina Eränkö
, Mette Ilander
, et al.
·
Orphanet Journal of Rare Diseases
·
30
PDF
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia
2012
·
Anna Kreutzman
, Taina Jaatinen
, et al.
·
Experimental Hematology
·
28
PDF
Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency
2020
·
Elina A. Tuovinen
, Juha Grönholm
, et al.
·
Journal of Clinical Immunology
·
27
PDF
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
2019
·
Anna Kreutzman
, Bhagwan Yadav
, et al.
·
OncoImmunology
·
26
PDF
Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease
2020
·
Daehong Kim
, Giljun Park
, et al.
·
Nature Communications
·
25
PDF
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
2017
·
Hanna L. M. Rajala
, Mohamed El Missiry
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
24
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients
2020
·
Henna Kasanen
, Micaela Hernberg
, et al.
·
Cancer Immunology Immunotherapy
·
22
PDF
Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy
2008
·
Satu Mustjoki
, Marja Ekblom
, et al.
·
Blood
·
21
Show more works
View as search
Works count:
232
Citation count:
1,383
H-index:
23
I10-index:
31
Year
Topic
Type